HLTH Heard in the Halls: Feyi Ayodele on Cancer's Next Chapter

In this special episode of HITea Heard in the Halls at HLTH, Feyi Ayodele, CEO of CancerIQ, joins Grace Vinton to discuss the company’s mission to end cancer through early detection, prevention, and personalized treatment.

Ayodele emphasizes that while the science of cancer innovation is advancing rapidly, the challenge lies in bringing those breakthroughs to real patients. She explores the balance between money and mission in today’s cancer landscape - where research budget cuts and health system constraints demand that innovations not only save lives but also demonstrate tangible ROI.